Development & Manufacturing / Newly Independent CDMO Skyepharma Looks to Expansion
Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director…
Top Stories
Switzerland / Upcoming Cost Containment Packages: Industry Key Concerns
While once considered the land of milk and honey within Europe in terms of market access and reimbursement for innovative pharmaceuticals, Switzerland is increasingly tightening its belt on this front…
Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Aducanumab Approval / Opening the Floodgates for a New Era of Alzheimer’s Treatment?
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Southeast Asia / Kalbe Underwhelms in Indonesia; Novavax Looks to Filipino Vaccine Manufacturing; Thai Cannabis Market Boom
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma,…
Mexico / Health & Patent Rights During the COVID-19 Pandemic
There is no doubt that COVID-19 has impacted almost every aspect of our lives. Due to the ongoing health crisis,…
In Conversation
Philipp Haas – Chairman of BOD & CEO, DEVA
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the company’s presence and strategy in international markets, how the firm is leveraging its three US FDA-approved and EU GMP-certified production facilities to build a quality-focused image, and how a raft…
Latest Reports
Focus on Switzerland
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Read more: Switzerland >>
Focus on Singapore
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
APAC: Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations…
Read more: Singapore >>
Focus on Vaccines
Sputnik V: A Brief History of Russia’s Controversial Viral…
Although Russian authorities received heavy criticism for approving the Sputnik…
Industry Warns of Vaccine Manufacturing Bottlenecks;…
Big Pharma’s representatives are warning of upcoming bottlenecks in the…
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more…
Southeast Asia: Kalbe Underwhelms in Indonesia; Novavax…
The latest from the pharma industry in Southeast Asia, including underwhelming…
Read more: Vaccines >>
Focus on USA
Mexico-US Vaccine Tourism: Closed Borders, Fear of Fakes…
While Mexico struggles with its COVID-19 vaccination campaign, residents of the…
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
US U-Turn as Biden Pledges Support for Waiver on COVID-19…
In a shock move, Joe Biden’s administration looks set to support a waiver on…
USA: Importance of the Patient Voice in Drug Development:…
Writing in the May edition of DIA’s Global Forum magazine, Erica Lyons, Sarrit…
Read more: USA >>
Focus on Europe
Spanish Pharma News: Market Growth; Esteve’s US Expansion;…
The latest from Spanish pharma, including the acquisition of PTS by a private…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Read more: Europe >>
Focus on China
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
China Pharma News: BioNTech-Fosun JV; Patent Law Revamp;…
The latest news from Chinese pharma, including an overhaul of the country’s…
APAC: Generic Penetration by Country
Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3…
Roche Hoping to Spearhead ‘Created in China’ Push with…
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai,…
Read more: China >>
Focus on MEA
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
Georg Schroeckenfuchs of Novartis: ‘Shooting for the…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…